ASTRAZENECA PLC financials
Also U.S.-listed. ASTRAZENECA PLC is also a foreign private issuer filing with the U.S. SEC. View its EDGAR financials: AZN — ASTRAZENECA PLC
ASTRAZENECA PLC
Country: GB Reporting currency: USD Latest annual report: 2025-12-31
LEI:
PY6ZZQWO2IZFZC3IOL08 Financial statements
(USD, as reported — unscaled; 129 line items across 3 annual periods)
| Line item | 2025 | 2024 | 2023 |
|---|---|---|---|
| Income statement | |||
| Revenue | $58.74B | $54.07B | $45.81B |
| Cost of sales | $10.63B | $10.21B | $8.27B |
| Gross profit | $48.11B | $43.87B | $37.54B |
| Distribution costs | $579.0M | $555.0M | $539.0M |
| Operating profit (EBIT) | $13.74B | $10.00B | $8.19B |
| Finance costs | $1.69B | $1.74B | $1.63B |
| Profit before tax | $12.40B | $8.69B | $6.90B |
| Income tax expense | $2.17B | $1.65B | $938.0M |
| Profit for the year | $10.23B | $7.04B | $5.96B |
| — attributable to owners | $10.22B | $7.04B | $5.96B |
| — attributable to NCI | $8.0M | $6.0M | $6.0M |
| Total comprehensive income | $12.94B | $6.24B | $6.69B |
| Per share | |||
| Basic EPS | $6.60 | $4.54 | $3.84 |
| Diluted EPS | $6.54 | $4.50 | $3.81 |
| Free cash flow / share | $7.53 | $6.36 | $5.75 |
| Cash flow statement | |||
| Cash generated from operations | $18.74B | $15.92B | $13.79B |
| Net cash from operating activities | $14.57B | $11.86B | $10.35B |
| Net cash from investing activities | -$6.81B | -$7.98B | -$4.06B |
| Purchase of PP&E (capex) | $2.81B | $1.92B | $1.36B |
| Purchase of intangibles | $3.10B | $2.66B | $2.42B |
| Net cash from financing activities | -$7.54B | -$4.00B | -$6.57B |
| Dividends paid | $4.97B | $4.63B | $4.48B |
| Proceeds from borrowings | $15.0M | $6.49B | $3.82B |
| Repayments of borrowings | $2.03B | $4.65B | $4.94B |
| Lease liability payments | $372.0M | $316.0M | $268.0M |
| Net change in cash | $223.0M | -$115.0M | -$286.0M |
| Balance sheet | |||
| Total assets | $114.07B | $104.03B | — |
| Non-current assets | $85.35B | $78.21B | — |
| Property, plant & equipment | $12.96B | $10.25B | — |
| Right-of-use assets | $1.74B | $1.40B | — |
| Intangible assets & goodwill | $21.24B | $21.02B | — |
| Current assets | $28.72B | $25.83B | — |
| Inventories | $6.56B | $5.29B | — |
| Trade & other receivables | $15.18B | $12.97B | — |
| Cash & equivalents | $5.71B | $5.49B | — |
| Total equity | $48.72B | $40.87B | $39.17B |
| — attributable to owners | $48.67B | $40.79B | — |
| Non-controlling interests | $52.0M | $85.0M | — |
| Non-current liabilities | $34.74B | $35.30B | — |
| Long-term borrowings | $24.71B | $26.51B | — |
| Lease liabilities (non-current) | $1.42B | $1.11B | — |
| Current liabilities | $30.62B | $27.87B | — |
| Lease liabilities (current) | $382.0M | $339.0M | — |
| Trade & other payables | $25.28B | $22.46B | — |
| Deferred tax liabilities | $3.50B | $3.31B | — |
| Derived metrics | |||
| Free cash flow | $11.77B | $9.94B | $8.98B |
| Operating margin | 23.4% | 18.5% | 17.9% |
| Net margin | 17.4% | 13.0% | 13.0% |
| Return on equity | 21.0% | 17.2% | 15.2% |
| Cash conversion ratio | 1.42× | 1.68× | 1.74× |
| Capex coverage | 5.19× | 6.16× | 7.60× |
| Other reported items | |||
| Adjusted Weighted Average Shares | 1562.0M | 1563.0M | 1562.0M |
| Adjustments For Decrease Increase In Inventories | -$755.0M | -$131.0M | -$669.0M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -$1.73B | -$1.62B | -$1.43B |
| Adjustments For Depreciation and Amortisation Expense and Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | $5.73B | $6.69B | $5.39B |
| Adjustments For Finance Income Cost | -$1.33B | -$1.28B | -$1.28B |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | -$7.0M | -$28.0M | -$12.0M |
| Capital Redemption Reserve | $153.0M | $153.0M | — |
| Cash and Cash Equivalents If Different From Statement of Financial Position | $5.70B | $5.43B | $5.64B |
| Cash Flows From Used In Increase Decrease In Current Borrowings | $364.0M | -$31.0M | $161.0M |
| Changes In Equity | $7.85B | $1.71B | $2.11B |
| Comprehensive Income Attributable To Noncontrolling Interests | $16.0M | $5.0M | $6.0M |
| Comprehensive Income Attributable To Owners of Parent | $12.92B | $6.24B | $6.69B |
| Current Borrowings and Current Portion of Noncurrent Borrowings | $3.10B | $2.34B | — |
| Current Derivative Financial Assets | $90.0M | $54.0M | — |
| Current Derivative Financial Liabilities | $81.0M | $50.0M | — |
| Current Investments | $30.0M | $166.0M | — |
| Current Provisions | $686.0M | $1.27B | — |
| Current Tax Assets Current | $1.16B | $1.86B | — |
| Current Tax Assets Noncurrent | $1.39B | $0 | — |
| Current Tax Liabilities Current | $1.08B | $1.41B | — |
| Current Tax Liabilities Noncurrent | $700.0M | $238.0M | — |
| Deferred Tax Assets | $5.82B | $5.35B | — |
| Dividends Paid Ordinary Shares | $4.85B | $4.60B | $4.49B |
| Dividends Recognised As Distributions To Noncontrolling Interests | $6.0M | $4.0M | $4.0M |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | $46.0M | -$93.0M | -$60.0M |
| Finance Income | $360.0M | $458.0M | $344.0M |
| Gains Losses On Cash Flow Hedges Before Tax | $263.0M | -$129.0M | $266.0M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | $50.0M | -$25.0M | $12.0M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss | $94.0M | $43.0M | -$101.0M |
| Income Taxes Paid Refund Classified As Operating Activities | $2.85B | $2.75B | $2.37B |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -$257.0M | $61.0M | — |
| Increase Decrease Through Sharebased Payment Transactions | $719.0M | $660.0M | $579.0M |
| Increase Decrease Through Treasury Share Transactions | $43.0M | -$68.0M | — |
| Intangible Assets Other Than Goodwill | $37.85B | $37.18B | — |
| Interest Paid Classified As Operating Activities | $1.32B | $1.31B | $1.08B |
| Interest Received Classified As Investing Activities | $286.0M | $343.0M | $287.0M |
| Investment Accounted For Using Equity Method | $302.0M | $268.0M | — |
| Issue of Equity | $40.0M | $38.0M | $34.0M |
| Issued Capital | $388.0M | $388.0M | — |
| Liabilities | $65.36B | $63.16B | — |
| Merger Reserve | $448.0M | $448.0M | — |
| Net Assets Liabilities | $48.72B | $40.87B | — |
| Noncurrent Derivative Financial Assets | $498.0M | $182.0M | — |
| Noncurrent Derivative Financial Liabilities | $0 | $115.0M | — |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | $2.22B | $1.63B | — |
| Noncurrent Payables | $2.38B | $1.77B | — |
| Noncurrent Provisions | $918.0M | $921.0M | — |
| Noncurrent Recognised Liabilities Defined Benefit Plan | $1.10B | $1.33B | — |
| Other Adjustments For Noncash Items | $662.0M | -$121.0M | -$386.0M |
| Other Cash Payments To Acquire Interests In Joint Ventures Classified As Investing Activities | $10.0M | $158.0M | $80.0M |
| Other Comprehensive Income | $2.70B | -$800.0M | $733.0M |
| Other Comprehensive Income Before Tax Change In Fair Value of Financial Liability Attributable To Change In Credit Risk of Liability | $0 | $12.0M | -$6.0M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | $2.39B | -$957.0M | $608.0M |
| Other Comprehensive Income Before Tax Gains Losses From Investments In Equity Instruments | $188.0M | $139.0M | $278.0M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | $290.0M | $80.0M | -$406.0M |
| Other Comprehensive Income Before Tax Hedges of Net Investments In Foreign Operations | $14.0M | $39.0M | $44.0M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | $2.32B | -$988.0M | $766.0M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | $384.0M | $188.0M | -$33.0M |
| Other Inflows Outflows of Cash Classified As Investing Activities | $131.0M | $30.0M | $97.0M |
| Other Noncurrent Receivables | $1.33B | $930.0M | — |
| Other Operating Income Expense | $381.0M | $252.0M | $1.34B |
| Par Value Per Share | $0.25 | — | — |
| Payments From Changes In Ownership Interests In Subsidiaries | $183.0M | $0 | $0 |
| Payments To Acquire Or Redeem Entitys Shares | $521.0M | $81.0M | $0 |
| Proceeds From Issuing Shares | $40.0M | $38.0M | $33.0M |
| Proceeds From Other Longterm Assets Classified As Investing Activities | $0 | $78.0M | $32.0M |
| Proceeds From Sales of Intangible Assets Classified As Investing Activities | $136.0M | $123.0M | $291.0M |
| Proceeds From Sales of Investments Accounted For Using Equity Method | $0 | $13.0M | $0 |
| Proceeds From Sales of Property Plant and Equipment Classified As Investing Activities | $13.0M | $55.0M | $132.0M |
| Purchase of Other Longterm Assets Classified As Investing Activities | $229.0M | $96.0M | $136.0M |
| Reclassification Adjustments On Cash Flow Hedges Before Tax | $314.0M | -$177.0M | $145.0M |
| Research and Development Expense | $14.23B | $13.58B | $10.94B |
| Retained Earnings | $10.97B | $3.16B | — |
| Revenue From Sale of Goods | $55.57B | $50.94B | $43.79B |
| Selling General and Administrative Expense | $19.93B | $19.98B | $19.22B |
| Share of Profit Loss of Associates and Joint Ventures Accounted For Using Equity Method | -$7.0M | -$28.0M | -$12.0M |
| Share Premium | $35.27B | $35.23B | — |
| Weighted Average Shares | 1550.0M | 1550.0M | 1549.0M |
Methodology
Every line item above is a fact tagged in ASTRAZENECA PLC's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (USD), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.